Emergency/Compassionate Use - Membranous VSD Occluder
- Conditions
- VentricularVSDMembranousSeptalDefects
- Registration Number
- NCT00583505
- Lead Sponsor
- Abbott Medical Devices
- Brief Summary
Emergency/Compassionate use of the AMPLATZER Membranous VSD Occluder
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- NO_LONGER_AVAILABLE
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Emergency/compassionate use for patients not meeting the inclusion critera for the AMPLATZER Membranous VSD clinical trial
Exclusion Criteria
Not provided
Study & Design
- Study Type
- EXPANDED_ACCESS
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the AMPLATZER Membranous VSD Occluder's efficacy in membranous ventricular septal defects?
How does the AMPLATZER Membranous VSD Occluder compare to surgical repair in managing complex membranous VSDs?
Which biomarkers are associated with optimal patient selection for compassionate use of the AMPLATZER Membranous VSD Occluder?
What are the potential adverse events and management strategies for AMPLATZER Membranous VSD Occluder in emergency settings?
Are there alternative transcatheter devices or combination therapies for membranous VSDs compared to the AMPLATZER occluder?